Alphatec Plunges On Gloomy Outlook For Spine Market, 2Q Miss

Share this story with your network

NEW YORK (Dow Jones)–Shares of Alphatec Holdings Inc. (ATEC) plunged as the medical-device maker’s second-quarter results missed estimates, leading it to slash its full-year revenue guidance.

The company, which makes products for the surgical treatment of spine disorders, in March completed the purchase of France-based Scient’x S.A., though difficulties related to the international integration remain.

Chief Executive Dirk Kuyper said several factors contributed to the lower-than-expected results…

**SUBSCRIPTION REQUIRED**

Leave a Comment

Your email address will not be published. Required fields are marked *

*